Key facts
- This page summarizes Birgit Girshick's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Jun 2021, 17:58.
Birgit Girshick - 28 May 2021 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
- Reporting relationship
- Corporate Executive VP
- Issuer ticker
- CRL
- Reported as of
- 28 May 2021
- Net transaction value
- +$1,163,700
- SEC form
- 4
- Accepted by SEC
- 01 Jun 2021, 17:58:26 UTC
- Prior SEC filing
- 21 Nov 2023
- Next SEC filing
- 15 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Birgit Girshick
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Birgit Girshick filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 01 Jun 2021.
Change
- Previous filing in this sequence was filed on 21 Nov 2023.
- Current net transaction value: +$1,163,700.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,183
- Change %
- +4.1%
- Price
- $0.000000
- Shares after
- 30,243
- Date
- 28 May 2021
- Ownership
- Direct
- Footnotes
- F1
CRL
transaction
Common Stock
Tax liability
- Transaction value
- $73,006
- Shares
- -216
- Change %
- -0.71%
- Price
- $337.99
- Shares after
- 30,027
- Date
- 29 May 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRL
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $1,236,705
- Shares
- +3,659
- Change %
- Price
- $337.99
- Shares after
- 3,659
- Date
- 28 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,659
- Exercise price
- $337.99
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Unvested restricted stock units vest as follows: 295 on May 28, 2022, 296 on May 28, 2023, 296 on May 28, 2024 and 296 on May 28, 2025.
Footnote F2
Stock Options vest as follows: 914 on May 28, 2022, 915 on May 28, 2023, 915 on May 28, 2024 and 915 on May 28, 2025.